Government OKs sales of locally-produced flu vaccine for infant

Published: 2009-11-19 07:00:00

Updated: 2009-11-19 07:00:00

Korea's health authorities gave the green light to a local pharmaceutical company on November 16 to sell the nation's first vaccine for type-A (H1N1) influenza for infants aged from six months and less than 3 years.

Green Cross Corp. has completed its clinical tests for type A influenza vaccin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK